ClinicalTrials.gg
RecruitingNCT07503509Updated Mar 31, 2026

Physiological Study of High PEEP in Noninvasive Ventilation

An interventional study of high PEEP in Respiratory Failure With Hypoxia, sponsored by Chongqing Medical University. Recruiting at 1 site in China. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-03-31.

Sponsored by Chongqing Medical University · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as recruiting.
  • Registered 1 year 11 months after the study started (first participant enrolled Mar 2024, registered Mar 2026).
  • Started Mar 2024; still recruiting 2 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
18 Years to 100 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 93 studies in Respiratory Insufficiency with a site in China — 30 open to participants now, 30 under way, 1 of them phase 3. Respiratory Insufficiency · China.

Planned enrollment
39th of 57
50 · median 120
Started
2024
with 9 others
No phase
49 of 93
14 open now
Primary completion
2026-06
later than 13 of 29 live
Registered
82nd of 93
by date
Lead sponsor
2 of 93
Chongqing Medical University

Among the 93 studies in Respiratory Insufficiency with a site in China, this one is the 39th largest by planned enrollment of the 57 interventional ones that give a count, is one of 10 that started in 2024, is one of 49 with no phase, reaches primary completion later than 13 of the 29 other live ones, and was the 82nd registered.

Respiratory Insufficiency

1,371 studies on the registry are indexed under Respiratory Insufficiency; 266 are open to participants now.

Browse Respiratory Insufficiency studies →

Open to participants now

30 of the 93 studies in Respiratory Insufficiency with a site in China are open now. Recruiting first, the newest first:

24 more — sign in →

All 30 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 180 Respiratory Insufficiency studies recruiting now, 135 (75%) set no upper age limit and 18 (10%) stop at 75 or younger; 21 take children under 18; 20 take healthy volunteers.

This study: 18 Years to 100 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 93 studies in Respiratory Insufficiency with a site in China, or all of them as a file.
02

Study summary

To investigate the physiological effects of high positive end-expiratory pressure (PEEP) during noninvasive ventilation in patients with hypoxemic respiratory failure, and to elucidate the mechanisms underlying high PEEP-induced improvement in oxygenation.

03

Conditions studied

  • Respiratory Failure With Hypoxia

Keywords

  • noninvasive ventilation
  • PEEP
  • respiratory failure
04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age ≥ 18 years
  2. PaCO₂ ≤ 50 mmHg
  3. PaO₂/FiO₂ ≤ 300 mmHg
  4. Use of a noninvasive ventilator with esophageal pressure monitoring capability (e.g., Mindray SV70) -

Exclusion criteria

Exclusion Criteria:

  1. Respiratory failure caused by heart failure, asthma, or acute exacerbation of (COPD) (COPD as a comorbidity may be included)
  2. Pneumothorax
  3. Patients who refuse to participate in this trial -
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    High PEEP group

    PEEP is increased stepwise from 5 cmH₂O, with increments of 5 cmH₂O every 10-20 minutes until reaching 20 cmH₂O. Once PEEP reaches or exceeds 20 cmH₂O, increments are made every 3-5 minutes until the recruitment level is achieved (i.e., stepwise increases to 5, 10, 15, 20, 25, and 30 cmH₂O). Inspiratory pressure is adjusted simultaneously to maintain a constant pressure difference.

    Procedure: high PEEP

Interventions

  • Procedurehigh PEEP

    First, PEEP was set at 5 cmH₂O, and inspiratory pressure was adjusted to achieve a target tidal volume of 6-8 mL/kg. Fraction of inspired oxygen (FiO₂) was titrated to maintain peripheral oxygen saturation (SpO₂) between 88% and 92%. Subsequently, PEEP was increased in 5 cmH₂O increments every 10-20 minutes from the initial value of 5 cmH₂O. Once PEEP reached 20 cmH₂O or above, increments were made every 3-5 minutes until the recruitment level was achieved (i.e., PEEP was increased stepwise from 5 to 10, 15, 20, 25, and 30 cmH₂O). Inspiratory pressure was adjusted concurrently to maintain a constant pressure difference. Throughout the procedure, physiological parameters-including respiratory rate, oxygenation, work of breathing, and others-were collected.

06

What researchers measure

Primary outcomes

  1. Oxygenation

    The changes of SpO2/FiO2 from 5 to 30 cmH2O of PEEP.

    Time frame: From enrollment to 2 hours post-intervention

Secondary outcomes

  1. Respiratory rate

    Changes of respiratory rate from 5 to 30 cmH2O of PEEP

    Time frame: From enrollment to 2 hours post-intervention

  2. Blood pressure

    Changes of blood pressure from 5 to 30 cmH2O of PEEP

    Time frame: From enrollment to 2 hours post-intervention

  3. Heart rate

    Changes of heart rate from 5 to 30 cmH2O of PEEP

    Time frame: From enrollment to 2 hours post-intervention

  4. Diaphragmatic excursion

    Changes in diaphragmatic excursion across PEEP levels from 5 to 30 cmH₂O. Diaphragmatic excursion refers to the movement of the thoracic diaphragm during breathing, as assessed by ultrasound.

    Time frame: From enrollment to 2 hours post-intervention

  5. Diaphragm thickening fraction

    Changes in diaphragm thickening fraction across PEEP levels from 5 to 30 cmH₂O. Diaphragm thickening fraction is calculated based on the change in diaphragm thickness from end-expiration to end-inspiration (\[end-inspiration - end-expiration\]/end-expiration), as assessed by ultrasound.

    Time frame: From enrollment to 2 hours post-intervention

  6. Work of breathing

    Changes in work of breathing across PEEP levels ranging from 5 to 30 cmH₂O were assessed by monitoring esophageal pressure with an esophageal balloon catheter.

    Time frame: From enrollment to 2 hours post-intervention

  7. Electrical impedance tomography of the lung

    Changes in lung electrical impedance tomography were recorded across PEEP levels ranging from 5 to 30 cmH₂O. The electrical impedance tomography belt was placed around the chest at the level of the 4th to 5th intercostal spaces, and data were collected after the patient's breathing had stabilized.

    Time frame: From enrollment to 2 hours post-intervention

  8. Tidal volume

    Changes of tidal volume from 5 to 30 cmH2O of PEEP

    Time frame: From enrollment to 2 hours post-intervention

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • L'Her E, Deye N, Lellouche F, Taille S, Demoule A, Fraticelli A, Mancebo J, Brochard L. Physiologic effects of noninvasive ventilation during acute lung injury. Am J Respir Crit Care Med. 2005 Nov 1;172(9):1112-8. doi: 10.1164/rccm.200402-226OC. Epub 2005 Aug 4. PubMed 16081548 ↗
  • Yoshida T, Roldan R, Beraldo MA, Torsani V, Gomes S, De Santis RR, Costa EL, Tucci MR, Lima RG, Kavanagh BP, Amato MB. Spontaneous Effort During Mechanical Ventilation: Maximal Injury With Less Positive End-Expiratory Pressure. Crit Care Med. 2016 Aug;44(8):e678-88. doi: 10.1097/CCM.0000000000001649. PubMed 27002273 ↗
  • Morais CCA, Koyama Y, Yoshida T, Plens GM, Gomes S, Lima CAS, Ramos OPS, Pereira SM, Kawaguchi N, Yamamoto H, Uchiyama A, Borges JB, Vidal Melo MF, Tucci MR, Amato MBP, Kavanagh BP, Costa ELV, Fujino Y. High Positive End-Expiratory Pressure Renders Spontaneous Effort Noninjurious. Am J Respir Crit Care Med. 2018 May 15;197(10):1285-1296. doi: 10.1164/rccm.201706-1244OC. PubMed 29323536 ↗
  • Duan J, Han X, Bai L, Zhou L, Huang S. Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients. Intensive Care Med. 2017 Feb;43(2):192-199. doi: 10.1007/s00134-016-4601-3. Epub 2016 Nov 3. PubMed 27812731 ↗

Individual participant data

Plan to share: No — The informed consent form for this study clearly states that patients' data are only accessible to the research team and regulatory authorities when necessary, and shall not be disclosed to other individuals or institutions.Therefore, there is no plan to make data publicly available for this study.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2024 (actual). Primary completion is estimated for Jun 2026, 27 months after the start.

Of 360 non-industry interventional studies with no phase under Respiratory Insufficiency, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 47. This study's planned 27 months is above that.

Counting every sponsor, half of 376 studies reached it within 24 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 21, 2026
First posted
Mar 31, 2026
StartActual
Mar 26, 2024
Primary completionEst.
Jun 30, 2026
CompletionEst.
Jun 30, 2026
Last update
Mar 31, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07503509
Lead sponsor
Chongqing Medical University
Responsible party
Duan jun (attending physician, Chongqing Medical University) — Principal investigator
First posted
Mar 31, 2026
Start date
Mar 26, 2024
Primary completion
Jun 30, 2026 (estimated)
Completion
Jun 30, 2026 (estimated)
Last update
Mar 31, 2026

Study contacts

Jun Duan
Contact
duanjun412589@163.com
+86-89012680
Yiwei Min
Contact
496996728@qq.com
+8689012144
Jun Duan, MD
principal investigator · First Affiliated Hospital of Chongqing Medical University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion